Metabolon Debuts New Client Portal at Bio-IT World Expo
News Apr 30, 2014
Metabolon, Inc. announced the debut and impending launch of MetaboLync, the company’s innovative product offering which allows its clients to share, visualize, and explore metabolomics study results as a client directs. The company will unveil the capabilities of this new cloud-based software solution at the 2014 BIO-IT World Expo in Boston, Massachusetts on April 30th. Corey DeHaven, Metabolon’s VP of Information Systems, is the visionary architect of the company’s metabolomics data processing, analysis and storage systems. The company will exhibit, and Corey will provide, an introduction to the portal, including a demonstration of its capabilities, in an oral presentation within the Harnessing Data & Standards session.
“The MetaboLync client portal is our first informatics solution available to external users and further exemplifies our leadership position in metabolomics research and diagnostics. Extracting functional results from the information-rich metabolomics data stream is key to advancing our and our clients’ research. This portal will empower users to more effectively visualize and navigate thru their own results interactively,” commented Metabolon’s President and CEO, John Ryals.
Informatics solutions have played an active and critical role in building Metabolon’s leading biomarker discovery and metabolomics profiling platforms, DiscoveryHD4™ and TrueMass™. Metabolomics experiments generate a large amount of data, including both named and unnamed metabolites, group statistical analysis, and biological pathway annotations. Data visualization and analytical tools are required to aid in understanding the data, including relationships among detected metabolites and their effects on the underlying biology. MetaboLync leverages cloud-based resources and web service application program interfaces (APIs) to enable these functions. Equally important, this portal solution will enable Metabolon’s clients to directly access their metabolomics study results as well as final reports interpreted by our biochemists that detail the biological significance of those results. We expect MetaboLync portal access will be available to clients for active research studies on May 15th when the company plans to migrate to a new website platform.
Researchers have developed a new AI-driven platform that can analyse how pathogens infect our cells with the precision of a trained biologist. The platform, HRMAn (‘Herman’), which stands for Host Response to Microbe Analysis, is open-source, easy-to-use and can be tailored for different pathogens including Salmonella enterica.READ MORE